Cleveland Clinic | 12th Annual Obesity Summit
Avatar

Management of Hypertension and Hyperlipidemia in Type 2 Diabetes

By Cleveland Clinic | 12th Annual Obesity Summit FEATURING Steven Nissen
December 2017
2 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Didactic Presentations

24th Pan Arab Conference on Diabetes

Fri, Mar 27, 2020
See 1 other
Didactic Presentations

ACC Satellite

Fri, Mar 27, 2020
16:56
William White

Ambulatory Blood Pressure Monitoring

10:03
Scripps Health: 2019 Updates in Diabetes Management

Multi-specialty Approach to Diabetes, Discussion with Nephrology

Feat. K. Harper
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition

Feat. R. DeFronzo
18:26
ARCH Advanced Revascularization Symposium

Hypertension 2016: Guidelines and Updates

28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty Aci...

Feat. R. Mason
15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

20:26
25th Annual San Diego Heart Failure Symposium

What’s New in Treating Hyperlipidemia: Update on PCSK9 Inhibition and Tr...

Feat. P. Taub
29:14
Michael Ozner

The Role of Omega-3 Fatty Acids for the Treatment and Prevention of Card...

21:16
National Lipid Association

Pearls from 34 Years of Running a Lipid Clinic

Feat. A. Brown
13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

28:22
Richard Auchus

Primary Aldosteronism and Implications for Primary Hypertension

18:42
Bonita Falkner

Recent Advances in Pediatric Hypertension

04:42
Cleveland Clinic Heart and Vascular Institute

Heart Outcomes Prevention Evaluation–3 - HOPE-3 Trial

Feat. S. Nissen
27:02
ASPC 2019 Congress on CVD Prevention

Expanded use of CAC testing in 2018 Cholesterol Guidelines- How to Apply?

Feat. R. Blankstein
53:27
Savitha Subramanian

Lipid Lowering: The Story Beyond Statins

16:12
ASPC 2018 Congress on CVD Prevention

Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Hi...

Feat. P. Moriarty
28:09
ASPC 2019 Congress on CVD Prevention

LDL-C lowering and the Brain: Differentiating Fact from Fiction

Feat. P. Toth
45:19
ASPC 2019 Congress on CVD Prevention

REDUCE-IT and Treating Beyond LDL-C Lowering

Feat. D. Bhatt
07:03
UC Davis Health Diabetes and Endocrinology Symposium

Diabetes and the Kidney

Feat. S. Ananthakrishnan
14:18
Richard Heuser

Immediate Blood Pressure Response: Non-Vascular Treatment for Resistant ...